Tower Research Capital (TRC)’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.35K Sell
665
-105
-14% -$1.61K ﹤0.01% 3932
2025
Q4
$9.78K Buy
+770
New +$10.5K ﹤0.01% 3873
2023
Q3
Sell
-61
Closed -$724 6038
2023
Q2
$724 Sell
61
-4,014
-99% -$41.2K ﹤0.01% 5562
2023
Q1
$33K Buy
4,075
+2,898
+246% +$26.6K ﹤0.01% 2894
2022
Q4
$11K Sell
1,177
-2,206
-65% -$23.9K ﹤0.01% 3816
2022
Q3
$39K Buy
3,383
+2,486
+277% +$31.4K ﹤0.01% 3375
2022
Q2
$8K Buy
+897
New +$11.7K ﹤0.01% 4674
2021
Q3
Sell
-837
Closed -$18K 5898
2021
Q2
$18K Buy
+837
New +$17.1K ﹤0.01% 3989

Other funds holding GHRS

Tower Research Capital (TRC)'s GHRS Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its GH Research (GHRS) stake by 14% in Q1 2026, selling an estimated $1.61K and leaving 665 shares worth $9.35K. The position accounts for ﹤0.01% of the portfolio, ranked #3932.

Tower Research Capital (TRC) first reported a position in GHRS in Q2 2021 and has held it in 8 quarters since. The position peaked at $39K in Q3 2022. 54 funds tracked by Wall St. Rank hold GHRS as of Q1 2026.

  • Tower Research Capital (TRC) held 665 shares of GH Research worth $9.35K as of Q1 2026.
  • Tower Research Capital (TRC) sold 105 GH Research shares in Q1 2026, an estimated $1.61K.
  • GH Research made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3932 holding.
  • Tower Research Capital (TRC) first reported a position in GH Research in Q2 2021 and has held it in 8 quarters since.
  • Tower Research Capital (TRC)'s GH Research position peaked at $39K in Q3 2022.
  • 54 funds tracked by Wall St. Rank held GH Research as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.